Federated Hermes’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.54M | Buy |
|
|||||
|
2025
Q2 | $1.78M | Buy |
|
|||||
|
2025
Q1 | $1.36M | Buy |
|
|||||
|
2024
Q4 | $2.66M | Buy |
|
|||||
|
2024
Q3 | $2.27M | Sell |
|
|||||
|
2024
Q2 | $1.86M | Buy |
|
|||||
|
2024
Q1 | $48.9K | Sell |
|
|||||
|
2023
Q4 | $51.4K | Sell |
|
|||||
|
2023
Q3 | $696K | Sell |
|
|||||
|
2023
Q2 | $1.85M | Sell |
|
|||||
|
2023
Q1 | $7.21M | Buy |
|
|||||
|
2022
Q4 | $7.96M | Buy |
|
|||||
|
2022
Q3 | $8.45M | Buy |
|
|||||
|
2022
Q2 | $684K | Sell |
|
|||||
|
2022
Q1 | $12.2M | Buy |
|
|||||
|
2021
Q4 | $29K | Sell |
|
|||||
|
2021
Q3 | $7.06M | Sell |
|
|||||
|
2021
Q2 | $9.16M | Sell |
|
|||||
|
2021
Q1 | $22.7M | Buy |
|
|||||
|
2020
Q4 | $20.7M | Buy |
|
|||||
|
2020
Q3 | $18.6M | Buy |
|
|||||
|
2020
Q2 | $11.2M | Sell |
|
|||||
|
2020
Q1 | $12.5M | Sell |
|
|||||
|
2019
Q4 | $13.9M | Sell |
|
|||||
|
2019
Q3 | $15.1M | Buy |
|
|||||
|
2019
Q2 | $13.1M | Buy |
|
|||||
|
2019
Q1 | $12M | Buy |
|
|||||
|
2018
Q4 | $14M | Buy |
|
|||||
|
2018
Q3 | $14.4M | Buy |
|
|||||
|
2018
Q2 | $8.51M | Sell |
|
|||||
|
2018
Q1 | $16.2M | Sell |
|
|||||
|
2017
Q4 | $22.8M | Buy |
|
|||||
|
2017
Q3 | $9.23M | Sell |
|
|||||
|
2017
Q2 | $8.31M | Buy |
|
|||||
|
2017
Q1 | $6.88M | Sell |
|
|||||
|
2016
Q4 | $7.91M | Sell |
|
|||||
|
2016
Q3 | $8.98M | Buy |
|
|||||
|
2016
Q2 | $5.79M | Sell |
|
|||||
|
2016
Q1 | $8.23M | Buy |
|
|||||
|
2015
Q4 | $8.94M | Buy |
|
|||||
|
2015
Q3 | $369K | Buy |
|